47045-QPA-C-IGAD-1 The Global Fund to Fight AIDS, Tuberculosis and Malaria <narrative>HIV/TB - Africa - Multicountry Eastern Africa IGAD (01-Oct-2016-31-Mar-2019)</narrative> Multicountry Eastern Africa IGAD, TB/HIV, Intergovernmental Authority on Development Goals: To contribute to the reduction of HIV/AIDS and TB related morbidity and mortality among cross border and mobile populations including refugees in IGAD member countries; To contribute to the reduction of new HIV infections and TB incidence among cross border and mobile populations including refugees in IGAD member countries. Objectives: To enhance the regional coordination and collaboration mechanisms for health service delivery and monitoring results in the IGAD region; To improve TB and HIV service access and utilization among the refugee populations in the IGAD region. The Global Fund to Fight AIDS, Tuberculosis and Malaria Intergovernmental Authority on Development Intergovernmental Authority on Development The Global Fund to Fight AIDS, Tuberculosis and Malaria The Global Fund to Fight AIDS, Tuberculosis and Malaria Communications +41 58 791 1700 website@theglobalfund.org https://www.theglobalfund.org The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland The Global Fund to Fight AIDS, Tuberculosis and Malaria Grant Management Division xxxx xxxx Fund Portfolio Manager +41 58 791 1700 xxxx https://www.theglobalfund.org The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland Multicountry Eastern Africa IGAD TB/HIV TB/HIV Ensure healthy lives and promote well-being for all at all ages End the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases, and combat hepatitis, water-borne diseases and other communicable diseases 7082622.00 Global Fund commitment to QPA-C-IGADP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria Intergovernmental Authority on Development 634300.00 Global Fund disbursement to QPA-C-IGADP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria Intergovernmental Authority on Development 557853.00 Global Fund disbursement to QPA-C-IGADP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria Intergovernmental Authority on Development 1035066.00 Global Fund disbursement to QPA-C-IGADP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria Intergovernmental Authority on Development 846998.00 Global Fund disbursement to QPA-C-IGADP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria Intergovernmental Authority on Development 1704760.00 Global Fund disbursement to QPA-C-IGADP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria Intergovernmental Authority on Development 5196841.00 Global Fund commitment to QPA-C-IGADP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria Intergovernmental Authority on Development -2303645.00 Global Fund commitment to QPA-C-IGADP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria Intergovernmental Authority on Development 1009265.00 Global Fund disbursement to QPA-C-IGADP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria Intergovernmental Authority on Development 990703.00 Global Fund disbursement to QPA-C-IGADP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria Intergovernmental Authority on Development 1000698.00 Global Fund disbursement to QPA-C-IGADP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria Intergovernmental Authority on Development 537886.00 Global Fund disbursement to QPA-C-IGADP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria Intergovernmental Authority on Development 133000.00 Global Fund disbursement to QPA-C-IGADP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria Intergovernmental Authority on Development 17000.00 Global Fund disbursement to QPA-C-IGADP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria Intergovernmental Authority on Development 12000.00 Global Fund disbursement to QPA-C-IGADP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria Intergovernmental Authority on Development 739408.00 Global Fund disbursement to QPA-C-IGADP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria Intergovernmental Authority on Development 27000.00 Global Fund disbursement to QPA-C-IGADP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria Intergovernmental Authority on Development 25920.00 Global Fund disbursement to QPA-C-IGADP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria Intergovernmental Authority on Development 428976.00 Global Fund disbursement to QPA-C-IGADP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria Intergovernmental Authority on Development 18240.00 Global Fund disbursement to QPA-C-IGADP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria Intergovernmental Authority on Development 20500.00 Global Fund disbursement to QPA-C-IGADP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria Intergovernmental Authority on Development 2852.00 Funds returned to the Global Fund from QPA-C-IGADP01. Intergovernmental Authority on Development The Global Fund to Fight AIDS, Tuberculosis and Malaria -2852.00 Global Fund commitment to QPA-C-IGADP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria Intergovernmental Authority on Development -236245.00 Global Fund commitment to QPA-C-IGADP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria Intergovernmental Authority on Development <narrative>Grant page on the data explorer of the Global Fund.</narrative> An overview of a grant over its lifetime. <narrative>Grant terms and conditions.</narrative> General terms and conditions which apply to Global Fund grants. <narrative>Number of cases with RR-TB and/or MDR-TB that began second-line treatment</narrative> Module: MDR-TB. <narrative>Number of cases with RR-TB and/or MDR-TB that began second-line treatment</narrative> Geographic coverage: National. Aggregation: Cumulative annually. <narrative>Percentage of other vulnerable populations that have received an HIV test during the reporting period and know their results</narrative> Module: Prevention programs for other vulnerable populations. <narrative>Percentage of other vulnerable populations that have received an HIV test during the reporting period and know their results</narrative> Geographic coverage: National. Aggregation: Cumulative annually. <narrative>Percentage of health facilities reporting no stock-outs of essential drugs</narrative> Module: RSSH: Health products management systems. <narrative>Percentage of health facilities reporting no stock-outs of essential drugs</narrative> Geographic coverage: National. Aggregation: Non cumulative. Numerator: 46; Denominator: 54. Numerator: 53; Denominator: 60. Numerator: 31; Denominator: 34. Numerator: 55; Denominator: 60. Numerator: 58; Denominator: 68. Numerator: 57; Denominator: 60. Numerator: 59; Denominator: 60. Numerator: 93; Denominator: 101. <narrative>Number of notified cases of all forms of TB (i.e. bacteriologically confirmed + clinically diagnosed), new and relapse cases</narrative> Module: TB care and prevention. <narrative>Number of notified cases of all forms of TB (i.e. bacteriologically confirmed + clinically diagnosed), new and relapse cases</narrative> Geographic coverage: National. Aggregation: Cumulative annually. <narrative>Percentage of people living with HIV currently receiving antiretroviral therapy</narrative> Module: Treatment, care and support. <narrative>Percentage of people living with HIV currently receiving antiretroviral therapy</narrative> Geographic coverage: National. Aggregation: Non cumulative - other. Numerator: 3102; Denominator: 8000. Numerator: 4000; Denominator: 8000. Numerator: 2758; Denominator: 8000. Numerator: 4250; Denominator: 8000. Numerator: 6986; Denominator: 8000. Numerator: 4500; Denominator: 8000. Numerator: 5000; Denominator: 8000. Numerator: 9567; Denominator: 10000.